Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Mobile App May Improve Glucose Management in Diabetes
Última actualización 12 de septiembre de 2026
Key finding
The TIR of the participants increased from 71.8% to 76% (P < 0.05).
This pilot randomized controlled trial evaluated the efficacy of the PROTEIN mobile app for glucose management in adults with prediabetes or type 2 diabetes, finding an increase in time in range.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot randomized controlled trial evaluated the efficacy of the PROTEIN mobile app for glucose management in adults with prediabetes or type 2 diabetes, finding an increase in time in range.
Clinical relevance
Improving time in range is crucial for individuals with prediabetes or type 2 diabetes as it can lead to better long-term health outcomes. The findings suggest that mobile health interventions like the PROTEIN app may be effective tools for enhancing glucose management, potentially reducing the risk of diabetes-related complications.
Keep in mind
Small sample size may limit generalizability. Short duration of the study may not capture long-term effects. Other health metrics showed no significant changes.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Javad S, Jiale Z, Oluwafayoke O, et al. Efficacy of a Personalized Mobile App for Glucose Management in Adults with Prediabetes or Type 2 Diabetes: A Pilot Randomized Controlled Trial. JMIR Human Factors. 2026;13:e87692. doi:10.2196/87692
Efectos Principales
Time in range (TIR) increased from 71.8% to 76% (P < 0.05).
Glycated hemoglobin (HbA1c) did not fluctuate during the intervention.
Fasting Plasma Glucose (FPG) remained stable throughout the study.
Body weight showed no significant changes over the 12-week period.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to PROTEIN mobile app and Body weight, Fasting Plasma Glucose (FPG), HbA1c, and 1 more.
This study contributes evidence to
Primary intervention
PROTEIN mobile app
Primary outcomes
- Body weight
- Fasting Plasma Glucose (FPG)
- HbA1c
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
4
Evidence pairs
4
Relationships
5
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
5
Related topics
4
Evidence pairs
1994
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 4 evidence relationships
- Includes primary outcome data
- Linked to 5 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
Glycemic Control
matched_outcome
Evidencia relacionada
Tema de evidencia
CGM Time in Range
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Fasting Plasma Glucose (FPG)
PROTEIN mobile app → Fasting Plasma Glucose (FPG)
PROTEIN mobile app → Fasting Plasma Glucose (FPG)
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 85
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- Time in range improved by 5% with the PROTEIN app (P < 0.05).
- No significant changes in HbA1c, FPG, or body weight.
- Effectiveness of the intervention remains unclear for other outcomes.
A quién se aplica
- Adults diagnosed with prediabetes or type 2 diabetes.
- Individuals seeking behavioral lifestyle interventions for glucose management.
Tener en Cuenta
- Results may not be applicable to broader populations due to sample size.
- The study duration was limited to 12 weeks, impacting long-term applicability.
- Further research is needed to clarify the effectiveness of the app on other health metrics.
Entre Líneas
- Small sample size may limit generalizability.
- Short duration of the study may not capture long-term effects.
- Other health metrics showed no significant changes.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on PROTEIN mobile app and Body Weight, PROTEIN mobile app and Fasting Glucose.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
PROTEIN mobile app → Body Weight
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
View evidenceBehavioral & Lifestyle
PROTEIN mobile app → Fasting Glucose
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Body Weight Evidence Hub
All studies measuring Body Weight
1 studies
outcome_hubMeasures Body Weight as a key outcome.
Fasting Glucose Evidence Hub
All studies measuring Fasting Glucose
1 studies
outcome_hubMeasures Fasting Glucose as a key outcome.
PROTEIN mobile app Evidence Hub
All studies on PROTEIN mobile app
1 studies
intervention_hubContributes to PROTEIN mobile app evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on PROTEIN mobile app and Body weight
Intervention: PROTEIN mobile appOutcome: Body weight
1 results
All studies on PROTEIN mobile app and Fasting Plasma Glucose (FPG)
Intervention: PROTEIN mobile appOutcome: Fasting Plasma Glucose (FPG)
1 results
All studies on PROTEIN mobile app
Intervention: PROTEIN mobile app
1 results
All studies measuring Body weight
Outcome: Body weight
1 results
All studies measuring Fasting Plasma Glucose (FPG)
Outcome: Fasting Plasma Glucose (FPG)
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does PROTEIN mobile app improve time in range?
Emerging Evidence
PROTEIN mobile app appears to improve time in range.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does PROTEIN mobile app affect body weight?
Emerging Evidence
Current evidence does not show a clear effect of PROTEIN mobile app on body weight.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does PROTEIN mobile app improve fasting plasma glucose (FPG)?
Emerging Evidence
Current evidence does not show a clear benefit of PROTEIN mobile app for fasting plasma glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does PROTEIN mobile app lower HbA1c?
Emerging Evidence
Current evidence does not show a clear benefit of PROTEIN mobile app for HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Insulin glargine plus metformin and glimepiride improves glycemic control in type 2 diabetes.Exercise Improves Serum Albumin Levels in Women with Type 2 DiabetesHRS-7535 improves glycemic control in adults with type 2 diabetesBariatric surgery improves glucose homeostasis in type 2 diabetes.CT-868 Improves Glycaemic Control in Type 2 Diabetes
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.